PharmaKang Biological (688046.SH) stated on the investor interaction platform on June 18th that the company operates seven large-scale production facilities in Nanjing, Jiangsu, Changzhou, Jiangsu, Foshan, Guangdong, Chengdu, Sichuan, Daxing, Beijing, and Baoshan, Shanghai, with a total capacity of approximately 280,000 cages, of which 80,000 cages are newly added capacity in 2023. Currently, the old capacity is at full production, and the new capacity is climbing according to the production plan.
药康生物(688046.SH)：目前老产能均处满产状态，新增产能按生产计划爬坡中
Yaokang Biotechnology (688046.SH): Currently, the old production capacity is fully utilized, and new production capacity is gradually being added according to production plans.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.